Search results
Results From The WOW.Com Content Network
JACC: Heart Failure in Top 15 With 2023 Impact Factor . Don’t Miss JACC: Heart Failure’s First Video Issue . Latest Findings Surrounding Heart Transplant Allocation Highlighted in Multi-Publication Bundle
JACC: Heart Failure publishes peer-reviewed articles on all aspects of heart failure, including original clinical studies, experimental investigations with clear clinical relevance, research letters, commentaries, and state-of-the-art papers.
ABSTRACT. | FULL TEXT. | PDF. For adults with advanced heart failure, class II/III obesity (body mass index ≥35 kg/m) represents major challenges, and it is even considered a contraindication for heart transplantation (HT) at many centers.
Heart failure (HF) is a leading cause of cardiovascular morbidity, mortality, and health care expenditure. Guideline-directed medical therapy and device-based therapy in HF are well established. However, the role of nonpharmacologic modalities ...
J Am Coll Cardiol HF. 2024 Jan, 12 (1) 1–15. Acute decompensated heart failure (ADHF) is one of the most common reasons for hospitalizations or urgent care and is associated with poor outcomes. Therapies shown to improve outcomes are limited, however, and innovation in pharmacologic and ...
Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients.
Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients.
Each JACC Patient Care Pathway is an immersive, multimedia case report depicting the integration of cross-specialty decision making supported by evidence-based medicine within a single patient journey.
We envision playing a vital and transformative role through the dissemination of the highest-quality science and knowledge across the whole spectrum of heart failure care, from prevention to advanced heart failure, to advance the field globally.
The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients’ interests.